Part two our three-part Executive Vision Forum White Paper discusses how biopharma can achieve innovations in medicine and remain competitive by preventing disease as opposed to reacting to it. This requires a proactive healthcare model - new technology, changes in the way we communicate with patients, and new structures to measure value and compensate physicians and pharma for the prevention solutions they deliver.